# Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer

> **NCT04331717** · PHASE2 · WITHDRAWN · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins**

## Conditions studied

- Prostate Adenocarcinoma
- Obesity, Morbid

## Interventions

- **DEVICE:** Bead Block 300-500 um
- **BEHAVIORAL:** Weight Management
- **DRUG:** Lupron

## Key facts

- **NCT ID:** NCT04331717
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-11-16
- **Primary completion:** 2023-08
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** accrual on hold
- **Last updated:** 2022-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04331717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04331717, "Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT04331717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*